loading

Why is Kintara Therapeutics Inc (KTRA) Stock down?

31 Oct, 2023:

Kintara Therapeutics Stock (KTRA) dropped by 79.68% from $3.76 to $0.764 in the trading on Tuesday October 31, 2023. The reason why KTRA stock down today is due to VAL-083 failure. The company has announced that their drug VAL-083 did not outperform existing treatments for glioblastoma, a severe brain cancer. Kintara is discontinuing the development of VAL-083 and shifting their focus to REM-001, a localized tumor treatment. Kintara will also explore strategic options to maximize shareholder value.

$21.36
price down icon 1.88%
$72.65
price down icon 0.68%
$23.34
price up icon 5.20%
$370.48
price up icon 0.61%
biotechnology ONC
$215.60
price down icon 1.09%
$116.42
price down icon 0.66%
Cap:     |  Volume (24h):